6d ago

Grail cancer blood test advances to major FDA regulatory review

GrailFDAcancer blood test

As of 2026-09-23, a blood test designed to detect multiple cancers in asymptomatic people is undergoing a significant U.S. regulatory review. Grail's test is facing its first major FDA approval hurdle.

2 reportslocal · us_mainstream

Claim audit

No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.

All coverage